Discovery of 500 tumor-specific cryptic peptides may guide future pancreatic cancer immunotherapies

Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer cells could be a promising target for T-cell therapies and other approaches that attack pancreatic tumors.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup